title: Attenuated nuclear shrinkage in neurones with nuclear inclusions of SCA1 brains.
abstract: BACKGROUND
  Spinocerebellar ataxia type 1 (SCA1) is one of the autosomal dominant neurodegenerative disorders commonly linked to pathological expansion of the CAG repeat of the relevant gene. Nuclear inclusions and neurodegeneration are both triggered by this pathological expansion of the CAG/polyglutamine repeat on ataxin-1, but it remains to be determined whether or not nuclear inclusion formation is associated with accelerated neurodegeneration.
  
  
  OBJECTIVE
  To examine the influence of nuclear inclusions on nuclear size and deformity in human brains from patients suffering from SCA1.
  
  
  METHODS
  Pontine sections of brains obtained at necropsy from seven patients with SCA1 and five controls.
  
  
  METHODS
  The size and deformity of each neuronal nucleus was quantified. Nuclei with and without inclusions were examined separately to assess the possible influence of nuclear inclusions on neurodegeneration.
  
  
  RESULTS
  Nuclear shrinkage and deformity were more marked in SCA1 brains than in controls. This shrinkage was attenuated in neurones containing nuclear inclusions.
  
  
  CONCLUSIONS
  The existence of nuclear inclusions in SCA1 is presumably linked to a mechanism that attenuates rather than accelerates nuclear shrinkage. This in vivo finding may provide a clue to constructing a rational therapeutic strategy for combating neurodegeneration associated with nuclear inclusions.
authors.affiliation: Department of Neurology, Tokyo Metropolitan Neurological Hospital, Tokyo, Japan.
authors.forename: U
authors.initials: U
authors.lastname: Nagaoka
authors.forename: T
authors.initials: T
authors.lastname: Uchihara
authors.forename: K
authors.initials: K
authors.lastname: Iwabuchi
authors.forename: H
authors.initials: H
authors.lastname: Konno
authors.forename: M
authors.initials: M
authors.lastname: Tobita
authors.forename: N
authors.initials: N
authors.lastname: Funata
authors.forename: S
authors.initials: S
authors.lastname: Yagishita
authors.forename: T
authors.initials: T
authors.lastname: Kato
mesh_terms: D000328:Adult; D000067696:Ataxin-1; D000067528:Ataxins; D002467:Cell Nucleus / Q000235:genetics / Q000473:pathology* / Q000502:physiology; D005260:Female; D006801:Humans; D002479:Inclusion Bodies / Q000235:genetics / Q000473:pathology* / Q000502:physiology; D008297:Male; D008875:Middle Aged; D009410:Nerve Degeneration / Q000235:genetics / Q000473:pathology* / Q000503:physiopathology; D009419:Nerve Tissue Proteins / Q000235:genetics / Q000502:physiology; D009474:Neurons / Q000473:pathology* / Q000502:physiology; D009687:Nuclear Proteins / Q000235:genetics / Q000502:physiology; D011149:Pons / Q000473:pathology / Q000503:physiopathology; D020754:Spinocerebellar Ataxias / Q000235:genetics / Q000473:pathology* / Q000503:physiopathology
chemical_list: C000593749:ATXN1 protein, human; D000067696:Ataxin-1; D000067528:Ataxins; D009419:Nerve Tissue Proteins; D009687:Nuclear Proteins